Cofoe Medical TechnologyLtd Yönetim

Yönetim kriter kontrolleri 4/4

Cofoe Medical TechnologyLtd CEO'su Min Zhang, Dec2019 tarihinde atandı, in görev süresi 4.92 yıldır. şirketin hisselerinin 5.84% doğrudan sahiptir ve bu hisselerin değeri CN¥ 457.94M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.6 yıl ve 3.4 yıldır.

Anahtar bilgiler

Min Zhang

İcra Kurulu Başkanı

CN¥493.6k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	4.9yrs
CEO sahipliği	5.8%
Yönetim ortalama görev süresi	3.6yrs
Yönetim Kurulu ortalama görev süresi	3.4yrs

Son yönetim güncellemeleri

Recent updates

Optimistic Investors Push Cofoe Medical Technology Co.,Ltd. (SZSE:301087) Shares Up 36% But Growth Is Lacking

Oct 09

Here's Why Cofoe Medical TechnologyLtd (SZSE:301087) Can Manage Its Debt Responsibly

Aug 22

Is Cofoe Medical TechnologyLtd (SZSE:301087) Using Too Much Debt?

May 22

CEO

Min Zhang (45 yo)

4.9yrs

Görev süresi

CN¥493,600

Tazminat

Mr. Zhang Min serves as Chairman of the Board and President at Cofoe Medical Technology Co.,Ltd. since December 25, 2019.

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Min Zhang	Chairman of the Board & President	4.9yrs	CN¥493.60k	5.84% CN¥ 457.9m
Zhiming Zhang	Vice Chairman & Executive VP	1.8yrs	CN¥1.01m	3.5% CN¥ 274.8m
Wangpeng Chen	VP & CFO	no data	CN¥1.02m	0.047% CN¥ 3.7m
Xiaoqiao Xue	VP, Board Secretary & Director	4.9yrs	CN¥1.02m	0.078% CN¥ 6.1m
Hanqing Zuo	Vice President	no data	CN¥792.10k	0.055% CN¥ 4.3m
Jie Ouyang	Vice President	1.8yrs	CN¥1.01m	0.0094% CN¥ 736.9k
Xiangyu Yu	Vice President	2.3yrs	CN¥1.08m	Veri yok

3.6yrs

Ortalama Görev Süresi

44yo

Ortalama Yaş

Deneyimli Yönetim: 301087 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.6 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Min Zhang	Chairman of the Board & President	4.9yrs	CN¥493.60k	5.84% CN¥ 457.9m
Zhiming Zhang	Vice Chairman & Executive VP	1.8yrs	CN¥1.01m	3.5% CN¥ 274.8m
Xiaoqiao Xue	VP, Board Secretary & Director	4.9yrs	CN¥1.02m	0.078% CN¥ 6.1m
Zhi Hao Wen	Independent Director	4.9yrs	CN¥80.00k	Veri yok
Aiming Liu	Independent Director	4.9yrs	CN¥80.00k	Veri yok
Bangjie He	Director	no data	CN¥1.02m	0.078% CN¥ 6.1m
Ziyun Xian Zeng	Chairman of the Supervisory Board	no data	Veri yok	Veri yok
Huabo Ning	Independent Director	1.8yrs	CN¥80.00k	Veri yok
Zizhuo Zhang	Non-Employee Supervisor	1.8yrs	Veri yok	Veri yok
Yufeng Liao	Employee Supervisor	1.8yrs	Veri yok	Veri yok

3.4yrs

Ortalama Görev Süresi

45yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 301087 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.4 yıldır).

Cofoe Medical TechnologyLtd Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Cofoe Medical Technology Co.,Ltd., Annual General Meeting, May 20, 2024

Cofoe Medical Technology Co.,Ltd. Approves Board Elections

Less than half of directors are independent

No independent directors

No independent directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.33 (vs CN¥0.21 in 3Q 2023)

Investor sentiment deteriorates as stock falls 18%

Optimistic Investors Push Cofoe Medical Technology Co.,Ltd. (SZSE:301087) Shares Up 36% But Growth Is Lacking

Upcoming dividend of CN¥0.60 per share

New minor risk - Share price stability

Cofoe Medical Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 16%

Cofoe Medical Technology Co.,Ltd. Approves Interim Dividend for the Year 2024

Cofoe Medical Technology Co.,Ltd. Announces the Profit Distribution Proposal for the First Half of 2024

Second quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.30 in 2Q 2023)

Here's Why Cofoe Medical TechnologyLtd (SZSE:301087) Can Manage Its Debt Responsibly

Cofoe Medical Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Cofoe Medical Technology Co.,Ltd. Announces Final Dividend of A Shares for 2023, Payable on 12 June 2024

Is Cofoe Medical TechnologyLtd (SZSE:301087) Using Too Much Debt?

New major risk - Revenue and earnings growth

New major risk - Dividend sustainability

Cofoe Medical Technology Co.,Ltd., Annual General Meeting, May 20, 2024

Cofoe Medical Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Investor sentiment deteriorates as stock falls 17%

Cofoe Medical Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.18 in 3Q 2022)

Cofoe Medical Technology Co.,Ltd. to Report Q3, 2023 Results on Oct 30, 2023

Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.38 in 2Q 2022)

Cofoe Medical Technology Co.,Ltd. Approves Profit Distribution Plan for 2022, Payable on 25 May 2023

Cofoe Medical Technology Co.,Ltd. Approves Profit Distribution Plan for 2022

Investor sentiment improves as stock rises 15%

First quarter 2023 earnings released: EPS: CN¥0.65 (vs CN¥0.24 in 1Q 2022)

Cofoe Medical Technology Co.,Ltd. Approves Board Elections

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.57 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.38 (vs CN¥0.55 in 2Q 2021)

Investor sentiment improved over the past week

Cofoe Medical Technology Co.,Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on May 20, 2022

First quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥1.09 in 1Q 2021)

No independent directors

Cofoe Medical Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2021

Investor sentiment improved over the past week

No independent directors

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş